MAIN CONTENT
Who should be screened, and when
For men with average prostate cancer risk, the American Cancer Society recommends PSA-based screening every two years from 50 through 69. This is a recommendation to offer regular screening, not a guarantee that testing benefits everyone equally. Clinicians should discuss possible false alarms, invasive follow-up and the patient's own priorities before initiating a testing schedule.
Risk changes the timetable. Black men and men with a strong family history—such as a father, brother or son diagnosed before 65, or several first-degree relatives affected—are advised to test annually from 45 to 69. For non-Black men with a single first-degree relative diagnosed at 65 or older, biennial screening can begin at 45. These distinctions acknowledge that a one-size-fits-all age threshold can miss important differences in risk.
Why a blood test is only the beginning
The PSA test measures a protein produced by prostate tissue. Cancer can raise PSA, but so can noncancerous enlargement, inflammation or temporary factors.















